Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
| 62.30 Delayed Data As of Sep 21 |  -0.10 / -0.16%Today’s Change | 41.60 Today|||52-Week Range 93.66 | -18.81% Year-to-Date |
Latest ARWR News | Press Releases
No recent news for Arrowhead Pharmaceuticals Inc.
Today’s Trading
| Previous close | 62.40 |
| Today’s open | 62.63 |
| Day’s range | 62.29 - 63.88 |
| Volume | 7,064 |
| Average volume (3 months) | 782,323 |
| Market cap | $6.7B |
Data as of 3:59pm ET, 09/21/2021
Growth & Valuation
| Earnings growth (last year) | -215.92% |
| Earnings growth (this year) | +17.52% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -47.87% |
| P/E ratio | NM |
| Price/Sales | 49.29 |
| Price/Book | 14.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FATEFate Therapeutics In... | +0.94 | +1.40% |
| ---- | ||
| BPMCBlueprint Medicines ... | +2.52 | +2.40% |
| DNLIDenali Therapeutics ... | +3.41 | +6.84% |
Data as of 4:00pm ET, 09/21/2021
Financials
| Next reporting date | December 14, 2021 |
| EPS forecast (this quarter) | $0.05 |
| Annual revenue (last year) | $88.0M |
| Annual profit (last year) | -$84.6M |
| Net profit margin | -96.09% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pasadena, California |
Forecasts
